RA Capital Nexus Fund III, Director, 10% Stockholder: Sionna Therapeutics SION Planned sale · Filed 25/11/20

Trade details

Type: Planned sale notice
Stock: Sionna Therapeutics SION
Person: RA Capital Nexus Fund IIIDirector, 10% Stockholder
Planned sale date: 25/11/20
Filed: 25/11/20

More to sell after $4.7M in 3 months

Sionna Therapeutics trades, last 26 weeks

What else happened in Sionna Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/21~25/12/20

RA Capital Nexus Fund III's recent trades

RA Capital Nexus Fund IIIDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$3.4M
391,019 sh
$3.4M
Filed 06/16
Traded 06/12
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$1.1M
124,893 sh
$1.1M
Filed 06/16
Traded 06/16

RA Capital Nexus Fund III, 10% Owner — plans to sell 1,313 sh of Sionna Therapeutics SION · $51.1K · around 11/20 | Whalegun